Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $196.24 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $95.32 | 7 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $87.40 | 1 | $0 (2017) |
| ABBVIE INC. | $13.52 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.52 | 1 | ABBVIE INC. ($13.52) |
| 2019 | $38.97 | 3 | Janssen Pharmaceuticals, Inc ($38.97) |
| 2018 | $56.35 | 4 | Janssen Pharmaceuticals, Inc ($56.35) |
| 2017 | $87.40 | 1 | Valeant Pharmaceuticals North America LLC ($87.40) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $87.40 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 344 | 4,676 | $368,504 | $105,180 |
| 2022 | 1 | 19 | 45 | $6,120 | $1,174 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 11 | 4,200 | $168,000 | $72,903 | 43.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 54 | 56 | $61,824 | $10,868 | 17.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 79 | 207 | $29,808 | $4,862 | 16.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 51 | 51 | $30,549 | $3,846 | 12.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 36 | 36 | $31,284 | $3,448 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 26 | $11,986 | $2,409 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 37 | $12,099 | $2,393 | 19.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $10,582 | $2,076 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,839 | $1,535 | 19.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 15 | $4,455 | $762.90 | 17.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 13 | $78.00 | $76.44 | 98.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 19 | 45 | $6,120 | $1,174 | 19.2% |
About Dr. Kristin Olson, DO
Dr. Kristin Olson, DO is a Internal Medicine healthcare provider based in Maple Grove, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2016. The National Provider Identifier (NPI) number assigned to this provider is 1194177469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristin Olson, DO has received a total of $196.24 in payments from pharmaceutical and medical device companies, with $13.52 received in 2022. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($196.24).
As a Medicare-enrolled provider, Olson has provided services to 363 Medicare beneficiaries, totaling 4,721 services with total Medicare billing of $106,354. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Maple Grove, MN
- Active Since 07/11/2016
- Last Updated 07/10/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194177469
Products in Payments
- XARELTO (Drug) $95.32
- XIFAXAN (Drug) $87.40
- VRAYLAR (Drug) $13.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Maple Grove
Dr. Prakash Viswanathan, M.d, M.D
Internal Medicine — Payments: $3,750
Dr. Srinivasa Vaka, Md, MD
Internal Medicine — Payments: $290.33
Dr. Karin Gilkison, M.d./M.p.h, M.D./M.P.H
Internal Medicine — Payments: $264.92
Dr. Rabia Khan, M.d, M.D
Internal Medicine — Payments: $204.58
Mr. Ahmed Omar, M.d, M.D
Internal Medicine — Payments: $170.14
Dr. Michael Farrell, Md, MD
Internal Medicine — Payments: $165.91